title: Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis.
abstract: Sertaconazole nitrate is a broad-spectrum antifungal agent indicated in the United States for the treatment of tinea pedis interdigitalis. The objective of this subgroup analysis was to evaluate the safety and efficacy of sertaconazole nitrate cream 2%, specifically in participants with tinea pedis interdigitalis (ie, fungal skin disease of the toe web) of dermatophyte origin. A total of 92 participants were included in this analysis. The primary end points were eradication of the pathogen (confirmed by fungal culture results) and reduction in total clinical score (TCS) of at least 2 points. Secondary end points included reducing signs and symptoms and reporting adverse events (AEs). After 4 weeks of treatment, 88.8% (79/89) of evaluable participants achieved success on the primary end points. Most participants also demonstrated substantial improvement in signs and symptoms after 4 weeks of treatment: 63.7% (58/91) were free of erythema, 33.0% (30/91) were free of desquamation, and 91.2% (83/91) were free of itch. The rate of reported AEs was low (8.7% [8/92]), and none were considered serious. These findings indicate that sertaconazole nitrate cream 2% is highly safe and effective in the treatment of tinea pedis interdigitalis.
authors.affiliation: Department of Dermatology and Allergology, Ludwig-Maximilians-Universität München, Munich. Germany. claudia.borelli@med.uni-muenchen.de
authors.forename: Claudia
authors.initials: C
authors.lastname: Borelli
authors.forename: Hans Christian
authors.initials: HC
authors.lastname: Korting
authors.forename: Rolf-Hasso
authors.initials: RH
authors.lastname: Bödeker
authors.forename: Claudia
authors.initials: C
authors.lastname: Neumeister
mesh_terms: D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D009824:Ointments; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects; D014008:Tinea Pedis / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; D007093:Imidazoles; D009824:Ointments; D013876:Thiophenes; C061131:sertaconazole